Oncology & Hematology Coding Alert

Reader Question:

Breast Cancer Returns in Lung

Question: How should we code a metastatic breast cancer in which the breast was removed in the 1980s but the cancer has returned in the lung? New Jersey Subscriber Answer: AHA guidelines dictate that "Any mention of extension, invasion, or metastasis to another site is coded as a secondary malignant neoplasm to that site. The secondary site may be the principal or first-listed with the V10 code [Personal history of malignant neoplasm] used as a secondary code."

The cancer that they found at this episode is a lung cancer, so it should be coded as secondary lung (197.0) followed by V10.3 (Personal history of breast cancer). Answers to the Reader Questions and You Be the Coder were provided by Mary Jo Griffin, RN, CPC, compliance officer with Practice Management Inc. of Boise, Idaho; Margaret M. Hickey, MS, MSN, RN, OCN, CORLN, an independent coding consultant based in New Orleans; Linda L. Lively, MHA, CCS-P, RCC, CHBME, founder and CEO of American Medical Accounting and Consulting in Marietta, Ga.; Cindy Parman, CPC, CPC-H, RCC, co-owner of Coding Strategies Inc., an Atlanta-based firm; and Elaine Towle, CMPE, practice administrator for New Hampshire Oncology and Hematology in Hooksett.
You’ve reached your limit of free articles. Already a subscriber? Log in.
Not a subscriber? Subscribe today to continue reading this article. Plus, you’ll get:
  • Simple explanations of current healthcare regulations and payer programs
  • Real-world reporting scenarios solved by our expert coders
  • Industry news, such as MAC and RAC activities, the OIG Work Plan, and CERT reports
  • Instant access to every article ever published in your eNewsletter
  • 6 annual AAPC-approved CEUs*
  • The latest updates for CPT®, ICD-10-CM, HCPCS Level II, NCCI edits, modifiers, compliance, technology, practice management, and more
*CEUs available with select eNewsletters.

Other Articles in this issue of

Oncology & Hematology Coding Alert

View All